CD8A and metastatic melanoma: In this study, we extend our previous work and show that nPKC-θ is enriched in mesenchymal CTCs and dysfunctional CD8+ T cells in aggressive metastatic cancers, namely TNBC brain metastases and immunotherapy-resistant metastatic melanoma.